Cellebrite DI (CLBT) Research & Development (2020 - 2025)

Cellebrite DI's Research & Development history runs 6 years deep, the most recent figure standing at $29.9 million for Q4 2025.

• In Q4 2025, Research & Development rose 16.66% year-over-year to $29.9 million; the TTM figure through Dec 2025 stood at $113.9 million (up 15.71% YoY), while the FY2025 annual figure was $113.9 million, up 15.71% from the prior year.
• Research & Development was $29.9 million for Q4 2025 at Cellebrite DI, up from $28.1 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $29.9 million in Q4 2025 to a low of $14.9 million in Q1 2021.
• Historically, Research & Development has averaged $22.1 million across 5 years, with a median of $21.4 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Research & Development jumped 31.7% in 2022, then dropped 5.47% in 2023.
• A 5-year view of Research & Development shows it stood at $18.8 million in 2021, then advanced by 4.78% to $19.7 million in 2022, then grew by 10.22% to $21.8 million in 2023, then increased by 17.69% to $25.6 million in 2024, then rose by 16.66% to $29.9 million in 2025.
• The last three Research & Development figures came in at $29.9 million (Q4 2025), $28.1 million (Q3 2025), and $28.6 million (Q2 2025), per Business Quant data.